LVGO - Livongo: Shockingly This Stock Is Still Undervalued
Investment Thesis
Livongo (LVGO) is a fast-growing company that has a very enticing health platform that keeps its members locked into monthly contracts.
I make the argument that Livongo is cheap, and that it's high gross profit margins are highly enticing, and that investors paying 52x trailing sales are not paying an irrational multiple to participate in this growth opportunity.
Growth at Breakneck Pace
Source: author's calculations, *updated guidance; ***high end company guidance
Livongo Health offers personalized health solutions. Livongo aims its services at people with chronic conditions, mainly diabetes, but it's attempting